Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Mcn 5691
2. Mcn-5691
3. N-(2-(3,4-dimethoxyphenyl)ethyl)-5-methoxy-n-dimethyl-2-(phenylethynyl)benzenepropanamine
1. Mcn5691
2. Mcn-5691
3. 99254-95-2
4. 6nz1chr0u7
5. Rwj-26240
6. Benzenepropanamine, N-(2-(3,4-dimethoxyphenyl)ethyl)-5-methoxy-n,alpha-dimethyl-2-(phenylethynyl)-
7. Unii-6nz1chr0u7
8. N-[2-(3,4-dimethoxyphenyl)ethyl]-4-[5-methoxy-2-(phenylethynyl)phenyl]-n-methylbutan-2-amine
9. Mcn 5691
10. Chembl352255
11. Schembl9218599
12. Dtxsid40912815
13. Rwj26240
14. Hy-u00218
15. Rwj 26240
16. Cs-7359
17. A813779
18. N-(2-(3,4-dimethoxyphenyl)ethyl)-5-methoxy-n-dimethyl-2-(phenylethynyl)benzenepropanamine
19. Benzenepropanamine, N-(2-(3,4-dimethoxyphenyl)ethyl)-5-methoxy-n,.alpha.-dimethyl-2-(2-phenylethynyl)-
20. N-(2-(3,4-dimethoxyphenyl)-ethyl)-5-methoxy-n,alphadimethyl-2-(phenylethynyl)benzenepropanamine
21. N-(2-(3,4-dimethoxyphenyl)ethyl)-5-methoxy-n,.alpha.-dimethyl-2-(2-phenylethynyl)benzenepropanamine
22. N-[2-(3,4-dimethoxyphenyl)ethyl]-4-[5-methoxy-2-(2-phenylethynyl)phenyl]-n-methyl-butan-2-amine
23. N-[2-(3,4-dimethoxyphenyl)ethyl]-5-methoxy-n,alpha-dimethyl-2-(phenylethynyl)benzenepropanamine
| Molecular Weight | 457.6 g/mol |
|---|---|
| Molecular Formula | C30H35NO3 |
| XLogP3 | 6.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 12 |
| Exact Mass | 457.26169398 g/mol |
| Monoisotopic Mass | 457.26169398 g/mol |
| Topological Polar Surface Area | 30.9 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 634 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A McN 5691 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of McN 5691, including repackagers and relabelers. The FDA regulates McN 5691 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. McN 5691 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A McN 5691 supplier is an individual or a company that provides McN 5691 active pharmaceutical ingredient (API) or McN 5691 finished formulations upon request. The McN 5691 suppliers may include McN 5691 API manufacturers, exporters, distributors and traders.
click here to find a list of McN 5691 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A McN 5691 DMF (Drug Master File) is a document detailing the whole manufacturing process of McN 5691 active pharmaceutical ingredient (API) in detail. Different forms of McN 5691 DMFs exist exist since differing nations have different regulations, such as McN 5691 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A McN 5691 DMF submitted to regulatory agencies in the US is known as a USDMF. McN 5691 USDMF includes data on McN 5691's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The McN 5691 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of McN 5691 suppliers with USDMF on PharmaCompass.
McN 5691 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of McN 5691 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right McN 5691 GMP manufacturer or McN 5691 GMP API supplier for your needs.
A McN 5691 CoA (Certificate of Analysis) is a formal document that attests to McN 5691's compliance with McN 5691 specifications and serves as a tool for batch-level quality control.
McN 5691 CoA mostly includes findings from lab analyses of a specific batch. For each McN 5691 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
McN 5691 may be tested according to a variety of international standards, such as European Pharmacopoeia (McN 5691 EP), McN 5691 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (McN 5691 USP).
LOOKING FOR A SUPPLIER?
